Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Prepaid Assets (2019 - 2026)

Nurix Therapeutics (NRIX) has disclosed Prepaid Assets for 8 consecutive years, with $13.7 million as the latest value for Q1 2026.

  • Quarterly Prepaid Assets fell 2.57% to $13.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Feb 2026, down 2.57% year-over-year, with the annual reading at $13.9 million for FY2025, 41.55% up from the prior year.
  • Prepaid Assets for Q1 2026 was $13.7 million at Nurix Therapeutics, down from $13.9 million in the prior quarter.
  • The five-year high for Prepaid Assets was $14.0 million in Q1 2025, with the low at $7.0 million in Q1 2024.
  • Average Prepaid Assets over 5 years is $10.0 million, with a median of $9.8 million recorded in 2024.
  • The sharpest move saw Prepaid Assets skyrocketed 177.38% in 2022, then plummeted 37.62% in 2024.
  • Over 5 years, Prepaid Assets stood at $9.3 million in 2022, then dropped by 18.4% to $7.6 million in 2023, then grew by 29.08% to $9.8 million in 2024, then skyrocketed by 41.55% to $13.9 million in 2025, then decreased by 1.56% to $13.7 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $13.7 million, $13.9 million, and $11.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.